CLASS II Device recall · Reported 28 Dec 2016 · FDA Enforcement Report

Aqure System recalled by Radiometer America

Radiometer America is recalling Aqure System, distributed in Michigan, New York. The recall was initiated on 23 Nov 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: (01)05700699335999(10)2.2.0
Quantity recalled7 total (2 in US)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0899-2017
FDA event ID
75836
Recalling firm
Radiometer America, Brea, CA
Classification
Class II
Status
Terminated
Recall initiated
23 Nov 2016
FDA classified
22 Dec 2016
Reported
28 Dec 2016
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay
Device type
Patient Monitors

Timeline

23 Nov 2016Recall initiated by company
22 Dec 2016Classified by FDA+29 days
28 Dec 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Design error when displaying additional information in the patient view window; error may result in misreading a parameter and its value.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

AQURE System Software Version 2.2.0 Model #: 933-599 UDI: (01)05700699335999(10)2.2.0 Catalog number: 933-599 The AQURE system manages Radiometer blood gas and immunoassay analyzers and results from 3rd party devices for point of care testing placed throughout the hospital. It enables the user to track connected devices, monitor performance and availability, and to quickly resolve and document issues (including allowing the customer to track root cause and corrective action taken). Intended use: The AQURE system is intended to let you manage analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets you send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use.

Where it was distributed

Worldwide Distribution - US including MI and NY and Internationally to England, Switzerland, and United Arab Emirates.

MichiganNew York

Questions about this recall

Why was it recalled?

Design error when displaying additional information in the patient view window; error may result in misreading a parameter and its value.

Which lots are affected?

UDI: (01)05700699335999(10)2.2.0

Where was it sold?

Worldwide Distribution - US including MI and NY and Internationally to England, Switzerland, and United Arab Emirates.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Radiometer America

All 24

Other Patient Monitors recalls

All 1,014